Maxidex

Dexamethasone, the active ingredient in Maxidex, is a corticosteroid presented as a 0.1% w/v ophthalmic solution for ocular (topical) use. It treats postoperative ocular inflammation, uveitis, allergic conjunctivitis and other anterior segment inflammatory conditions in patients who require anti‑inflammatory therapy.

GNH USA supplies Maxidex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet global demand. Our distribution network ensures reliable delivery across Europe, Asia, Africa and the Americas.

Maxidex (dexamethasone ophthalmic solution) is used to manage inflammatory conditions of the anterior eye segment.

- Postoperative ocular inflammation: reduces swelling, pain and redness after eye surgery. - Uveitis: suppresses intra‑ocular inflammation to preserve visual acuity. - Allergic conjunctivitis: alleviates itching, redness and swelling caused by allergens. - Anterior segment inflammation: controls inflammatory response in the cornea and iris.

Topical ocular dexamethasone may cause a range of local and systemic adverse reactions.

Common Side Effects: - Burning or stinging sensation upon instillation. - Temporary blurred vision. - Mild increase in intra‑ocular pressure. - Conjunctival hyperemia.

Serious or Rare Side Effects: - Secondary ocular infection (bacterial, fungal or viral). - Significant elevation of intra‑ocular pressure leading to glaucoma. - Delayed corneal wound healing or ulceration. - Cataract formation with prolonged use.

When prescribing Maxidex, clinicians should observe several safety considerations. - Monitor intra‑ocular pressure: schedule regular eye‑pressure assessments during therapy. - Avoid use in active ocular infection: corticosteroid action may exacerbate bacterial, viral or fungal infections. - Do not wear contact lenses: lenses can trap the solution and reduce drug efficacy. - Review systemic steroid use: concurrent systemic corticosteroids increase risk of systemic side effects. - Store at room temperature: keep in the original container, protect from light and moisture.

Maxidex can interact with other ophthalmic or systemic agents, influencing efficacy or safety.

Major Interactions (Avoid): - Other topical ocular corticosteroids: additive risk of intra‑ocular pressure rise and cataract. - Systemic immunosuppressants (e.g., cyclosporine): may enhance immunosuppression and infection risk.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory eye drops: possible reduction in anti‑inflammatory effect. - Beta‑blocker eye drops: may affect intra‑ocular pressure control. - Systemic CYP3A4 inducers (e.g., rifampin): may lower dexamethasone concentrations.